Waters Corporation Unveils MaxPeak Premier Oligonucleotide Columns
New column technology essential for development of new cell and gene therapies and vaccines
WHO: Waters Corporation, Milford, Massachusetts, USA
WHAT: Waters Corp introduces its newest MaxPeak Premier Oligonucleotide Columns – now with ethylene bridged hybrid (BEH) particle technology in 300Å wide pore versions – providing industry-leading chromatographic resolution for long-mer oligonucleotide separations to support applications for nucleic acid therapeutics and cell and gene therapies.
The new columns have all the benefits customers can expect from Waters’ MaxPeak Premier high performance surface chemistry and BEH particle technology – including enhanced sensitivity, reproducibility, and productivity with unmatched pH and temperature stability, which is essential for oligonucleotide/nucleic acid separations. The columns are available for both UPLC separations with Waters’ ACQUITY Premier Oligonucleotide BEH C18 columns and UHPLC/HPLC separations with Waters’ XBridge Premier Oligonucleotide BEH C18 columns.
WHY: Oligonucleotide analysis is changing with new modalities demanding more advanced technologies. Waters is a leader in oligonucleotide analysis with key methods and product developments that have advanced the field for more than 20 years.
New applications associated with nucleic acid therapeutics and vaccines require the ability to separate and analyze long-mer oligonucleotides, which was difficult to achieve with existing column technologies, until now. The Waters MaxPeak Premier Oligonucleotide BEH C18 300Å Columns enable high resolution separation of long-mer oligonucleotides. This means end users developing new gene-based therapeutics – such as mRNA poly(A) tail length and heterogeneity analysis for mRNA therapeutics and vaccines; single guide RNA (sgRNA) characterization for gene editing constructs; and mRNA oligo mapping and sequencing – can more quickly develop analytical methods and characterize the nucleic acid components of these drugs and their impurities.
- Learn more about the new Premier Columns for oligonucleotide analysis
- Register for an upcoming webinar from Dr. Martin Gilar: Achieving High Resolution LC Separations of Long-mer (>60mer) Oligonucleotides
- Read our application note Ion-Pair Reversed-Phase Liquid Chromatography Method for Analysis of mRNA Poly(A) Tail Heterogeneity
- Read our application note CRISPR Single Guide RNA Characterization by IP-RP-LC-MS with a Premier Oligonucleotide BEH C18 300Å Columns
- Connect with Waters via Twitter, Facebook, and LinkedIn
ABOUT: Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for over 60 years. With more than 8,400 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.Click Here.This email has been scanned for viruses and malware, and may have been automatically archived by Mimecast Ltd, an innovator in Software as a Service (SaaS) for business. Providing a safer and more useful place for your human generated data. Specializing in; Security, archiving and compliance. To find out more